Mechanismof 5 Azacytidine-inducedTransfer RNACytosine-5-methyltransferaseDeficiency 1

The administration of 5-azacytidine to mice leads to a spe cific, rapid, time-dependent, and dose-dependent decrease of transfer RNA (IRNA) cytosine-5-methyltransferase activity of mouse liver and the synthesis of lANA specifically lacking 5methylcytidlne. The mechanism of this enzyme deficiency was investigated. The pretreatment of mice with RNA synthesis inhibitors such as actinomycin D and D-galactosamine pre vented the enzyme deficiency induced by 5-azacytidine admin istration. These results suggested that RNA synthesis was a prerequisite for the induction by 5-azacytidine of the enzyme inhibition in vivo. Indeed, a slowly sedimenting RNA (4 to 75) from the livers of mice treated with 5-azacytidine, when present in an in vitro tRNA methyltransferase assay, decreased specif ically the activity of tRNA cytosine-5-methyltransferase. The pretreatment of mice with actinomycin D or D-galactosamine prior to the administration of 5-azacytidine effectively pre vented the formation of such inhibitory RNA in vivo as deter mined by an in vitro tRNA methyltransferase assay. These results indicate that the administration of 5-azacytidine to mice leads to the rapid synthesis of a low-molecular-weight RNA fraction which is capable of specifically inactivating tRNA cy tosine-5-methyltransferase activity in vivo and in vitro.

[1]  L. Lu,et al.  Effects of 5-azacytidine on transfer RNA methyltransferases. , 1979, Cancer research.

[2]  L. Lu,et al.  Effects of 5-fluorocytidine on mammalian transfer RNA and transfer RNA methyltransferases. , 1979, Biochemical pharmacology.

[3]  K Randerath,et al.  Specific inhibition of transfer RNA methylation and modification in tissues of mice treated with 5-fluorouracil. , 1978, Cancer research.

[4]  J. Veselý,et al.  5-Azacytidine: Mechanism of action and biological effects in mammalian cells , 1978 .

[5]  D. V. Von Hoff,et al.  5-azacytidine--a new anticancer drug with significant activity in acute myeloblastic leukemia. , 1977, Advances in pharmacology and chemotherapy.

[6]  K. Randerath,et al.  Effects of 5-fluorouridine on modified nucleosides in mouse liver transfer RNA. , 1976, Biochemical and biophysical research communications.

[7]  K. Randerath,et al.  Drug effects on nucleic acid modification. I. A specific effect of 5-azacytidine on mammalian transfer RNA methylation in vivo. , 1976, Biochemical and biophysical research communications.

[8]  A. Pegg,et al.  Studies of the base composition of transfer rna and the specificity of transfer rna methylases of hamster liver , 1975 .

[9]  D. Keppler,et al.  Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis. , 1974, The Journal of biological chemistry.

[10]  A. Čihák Biological effects of 5-azacytidine in eukaryotes. , 1974, Oncology.

[11]  E. Freireich,et al.  Treatment of acute leukemia with 5-azacytidine (NSC-102816). , 1973, Cancer chemotherapy reports.

[12]  J. Finklestein,et al.  5-Azacytidine: a new active agent for the treatment of acute leukemia. , 1973, Blood.

[13]  K. Randerath,et al.  Base analysis of ribopolynucleotides by chemical tritium labeling: a methodological study with model nucleosides and purified tRNA species. , 1972, Analytical biochemistry.

[14]  J. Veselý,et al.  5-azacytidine in childhood leukemia. , 1971, Neoplasma.

[15]  R. Perry,et al.  Inhibition of RNA synthesis by actinomycin D: Characteristic dose‐response of different RNA species , 1970, Journal of cellular physiology.